Latest news
Symposium series | Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors - lymphomahub.comlymphomahub.com · Fri, 07 Aug 2026 19:18:15 GMTComparing CV Safety and Exploratory Bleeding Outcomes of BTK Inhibitors in Mantle Cell Lymphoma - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 05 Aug 2026 20:44:48 GMTCombining BTK and BCL2 Inhibitors in Mantle Cell Lymphoma: Eyre Weighs in on Where the Field Goes Next - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 05 Aug 2026 20:31:11 GMTDr Mulvey on Real-World Treatment Discontinuation Data for First-Line BTK Inhibitors in CLL - OncLiveOncLive · Wed, 05 Aug 2026 03:19:51 GMTBTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives - OncodailyOncodaily · Mon, 03 Aug 2026 00:05:55 GMTBTK Inhibitors Play An Important Role In CLL Treatment & Management - SurvivorNetSurvivorNet · Fri, 31 Jul 2026 19:56:41 GMTCLL Treatment: What Side Effects Can I Expect From BTK Inhibitors? - SurvivorNetSurvivorNet · Fri, 31 Jul 2026 18:43:17 GMTSymposium | BTK inhibitors in practice: Treatment selection and emerging clinical evidence - lymphomahub.comlymphomahub.com · Fri, 31 Jul 2026 11:14:32 GMT